Navigation Links
New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis

NEW YORK, Sept. 1 /PRNewswire/ -- Women with ovarian cancer can now find immediate assistance to better cope with their diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone counseling and referral service launched today by a unique partnership: L'Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund (OCRF), and CancerCare, a national non-profit which provides free counseling and education services to individuals and families affected by cancer.

"Any cancer diagnosis is a frightening and stressful experience that can be difficult to cope with," noted Rosalie Canosa, director of program services for CancerCare. "When the diagnosis is ovarian cancer, too many women have no place to turn for help with the emotional and practical impact of their situation."

Ovarian cancer is the eighth most common cancer among U.S. women. This year, approximately 22,000 women will be diagnosed, and nearly 15,000 will lose their lives to the disease, according to the National Cancer Institute. While five-year survival rates exceed 90 percent in early-stage diagnoses, there is no effective early-stage test for the disease, which often is not diagnosed until it reaches an advanced stage, when it is far more difficult to treat successfully.

"Now, with the L'Oreal Paris OCRF Hope Line, women facing ovarian cancer can have their questions answered and find the resources they require to ensure they receive the best care possible," said Canosa.

"We at L'Oreal Paris are deeply committed to providing tangible hope for women battling ovarian cancer," said Karen T. Fondu, president of the L'Oreal Paris Division of L'Oreal USA, Inc. "With the L'Oreal Paris OCRF Hope Line, we hope to continue to work to improve the five-year survival rate for women and provide support along the way."

"OCRF and our dedicated corporate partner, L'Oreal Paris, have been working together for over 12 years to empower women, and to give them hope when they face a diagnosis of ovarian cancer," said Elizabeth Howard, CEO of OCRF. "By joining forces with CancerCare and creating the call center, we are all better able to help women across the United States."

L'Oreal Paris and OCRF generously funded the Hope Line, which is staffed by CancerCare's professional oncology social workers. The Hope Line operates Monday through Friday, 9 a.m. to 5 p.m. Eastern Time.

For more information about the L'Oreal Paris OCRF Hope Line, contact Jeanie M. Barnett, CancerCare director of communications, at 212-712-6137; or email

About CancerCare

CancerCare is a national non-profit organization that provides free, professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs - including counseling, education, financial assistance and practical help - are led by professional oncology social workers and are completely free of charge. Founded in 1944, CancerCare now provides individual help to more than 100,000 people each year, and has more than one million unique visitors annually to its websites. For more information, call 1-800-813-HOPE (4673) or visit

About L'Oreal Paris

The L'Oreal Paris Brand Division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oreal Paris brand encompasses the four major beauty categories - haircolor, haircare, skincare and cosmetics - and includes such well-known brands as Preference and Excellence haircolors; VIVE Pro, Studio Line, and L'Oreal Kids haircare; Revitalift, Age Perfect, Skin Genesis, Sublime Bronze and Men's Expert skincare; Colour Riche, True Match, Bare Naturale, Infallible cosmetics collections, a portfolio of mascara including Voluminous, Double Extend and Telescopic among many others, and the HIP High Intensity Pigments line. For more information on L'Oreal Paris and its brands, and to get comprehensive, personalized beauty information from the experts, visit

L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to raising awareness and funds for ovarian cancer. To date, L'Oreal Paris has helped raise more than $18 million dollars to further research and build awareness with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal's annual "Color of Hope" cosmetics collection.

For more information, please visit

About the Ovarian Cancer Research Fund

OCRF is the leading independent organization in the U.S. dedicated to advancing ovarian cancer research. OCRF was founded in 1994 by Sol Schreiber to honor the memory of his wife Ann, a distinguished public administrator, and her courageous five-year battle with ovarian cancer. Under the leadership of Liz Tilberis, the beloved late editor-in-chief of Harper's Bazaar, OCRF gained national prominence as an organization committed to changing the course of this deadly disease. Since 1998, OCRF has awarded over $30 million in grants to researchers across the country. For more information, visit or call 212-268-1002.

SOURCE CancerCare
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Clinical Trials Offices Changing Academic Health Center Research Infrastructure
2. LASIK Expert Edward Manche, M.D., of the Stanford Eye Laser Center Joins Top Surgeons Listed at the Trusted LASIK Surgeons Directory
3. MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging
4. New Jersey Surgery Centers Pick Health Informatics Consulting to Implement Patient Electronic Health Record Systems
5. UCI chemistry center awarded $20 million from NSF
6. Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Childrens Medical Center
7. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
8. Yongye International Announces Expansion of Research and Development Center
9. The National Center for Genome Resources Studies Childhood Diseases Using febits DNA Capture Method
10. DOE awards $377 million in funding for 46 energy frontier research centers
11. W.M. Keck Foundation Awards $1 Million to Hutchinson Center Scholar to Study How Cells Go Awry
Post Your Comments:
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... 2 nouvelles études permettent d ... différences entre les souches bactériennes retrouvées dans la plaque ... humains . Ces recherches  ouvrent une nouvelle ... charge efficace de l,un des problèmes de santé ... .    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
Breaking Biology Technology:
(Date:11/17/2015)... November 17, 2015 Paris ... --> Paris from 17 th ... the biometrics innovation leader, has invented the first combined scanner ... the same scanning surface. Until now two different scanners were ... scanner can capture both on the same surface. This ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
Breaking Biology News(10 mins):